FREE EXPRESS DELIVERY ON ORDERS A$200+
PEPTALIAS — Australian research peptides
Menu
PEPTALIAS Retatrutide 10 mg research vial

Retatrutide

Strength
10 mg
Vial
3 mL
Supplier COA
Reported purity
99.4%
Report batch
RETA-2026-169

This is a supplier-provided report. Results apply to the sample identified in the report. One COA is shared across a product's strength options.

Certificate of Analysis (COA)How to read this COA
Choose strength

Selected strength: 10 mg

Price per 10 mg vialA$129.99

In stock

Quantity
1
Retatrutide · 10 mgA$129.99
Product information & FAQs Details, research sources and common questions

Product details

Retatrutide is a synthetic peptide that activates three receptors: GIP, GLP-1 and glucagon.

Research & sources

A 2023 phase 2 trial involved 281 adults with type 2 diabetes. Researchers measured HbA1c (a marker of average blood sugar) at 24 weeks and body weight at 36 weeks. Most retatrutide groups showed larger reductions in both than the placebo group.

Rosenstock et al., The Lancet (2023)

Not medical advice. These products are intended for lawful research use only and are not for human or veterinary use.

FAQs

What format is supplied?

The selected listing is 10 mg, supplied in a 3 mL vial. The displayed price is per vial.

Is BAC Water included?

No. BAC Water is a separate laboratory supply and is not included with this vial.

When will it be dispatched?

In-stock orders are dispatched the next business day. Delivery after dispatch: Metro 2–5 business days · Regional 3–7 business days. See business details.

What is the intended use?

This listing is offered only for lawful laboratory or analytical research. It is not for human or veterinary use, and PEPTALIAS does not provide dosing or administration guidance.

View all
Concentration simulatorOpen the interactive Retatrutide lab

Select the vial size and listed compound amount, then enter your liquid volume and your own research sample amount.

Loading simulator…